Recombinant glucarpidase G2 (Kerun Biopharmaceutical)

重组羧肽酶G2（重庆科润生物医药）

Report date: 2022/07/19 16:22:54

Base Information

Drug NameRecombinant glucarpidase G2 (Kerun Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionMethotrexate metabolizersGlutamate carboxypeptidase II replacements
TargetsMethotrexate
Therapy Area/IndicationsDrug intoxicationsDrug Overdose
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Inactive CompaniesN/A
Active IndicationsDrug intoxications
Inactive IndicationsDrug Overdose

Other Information

ATC CodeN/A
Related LinksN/A